Literature DB >> 17503081

Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins.

Liang Zhao1, Li Liu, Shuang Wang, Yan-fei Zhang, Li Yu, Yan-qing Ding.   

Abstract

PURPOSE: Metastasis is a common phenomenon and the major lethal cause of colorectal carcinoma (CRC). To better comprehend the mechanism underlying CRC metastasis and to search for potential markers for predicting CRC metastasis, two CRC cell lines with different metastatic potentials, SW480 and SW620, were investigated by phenotypic analyses and proteomics technologies.
METHODS: The surgical orthotopic implantation (SOI) technique was originally used to develop a reproducible colorectal cancer model in nude mice with stable tumor growth and metastasizing course. Furthermore, differential proteome analysis of two CRC cell lines was conducted using two-dimensional (2-D) gel electrophoresis combined with matrix-assisted laser desorption/time of flight (MALDI-TOF) mass spectrometry.
RESULTS: Among the differential spots, 12 protein spots (11 proteins) were further identified using in-gel tryptic digestion and peptide mass fingerprinting (PMF). Interestingly, most of these proteins we identified have been reported to be associated with distinct aspect of tumor metastasis to some extent. Our immunohistochemistry assays of colorectal cancer revealed that heat shock protein (HSP) 27 overexpression relates to metastatic behavior of CRC cell.
CONCLUSIONS: The protein profile between two colorectal cell lines with different potential metastasis displayed obvious differences. The results imply that various different proteins may lead to CRC metastasis together. HSP27 overexpression played an important role in metastasis and progression of CRC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503081     DOI: 10.1007/s00432-007-0222-0

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  29 in total

1.  The DNA architectural protein HMGB1 displays two distinct modes of action that promote enhanceosome assembly.

Authors:  Katherine Mitsouras; Ben Wong; Charina Arayata; Reid C Johnson; Michael Carey
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

3.  Polyamine metabolism in primary human colon adenocarcinoma cells (SW480) and their lymph node metastatic derivatives (SW620).

Authors:  B Duranton; V Holl; Y Schneider; S Carnesecchi; F Gossé; F Raul; N Seiler
Journal:  Amino Acids       Date:  2003       Impact factor: 3.520

4.  Chromosomal markers associated with metastasis in two colon cancer cell lines established from the same patient.

Authors:  S Gagos; V L Hopwood; D Iliopoulos; A Kostakis; P Karayannakos; H Yatzides; G D Skalkeas; S Pathak
Journal:  Anticancer Res       Date:  1995 Mar-Apr       Impact factor: 2.480

5.  The motility of glioblastoma tumour cells is modulated by intracellular cofilin expression in a concentration-dependent manner.

Authors:  Celestial T Yap; T Ian Simpson; Thomas Pratt; David J Price; Sutherland K Maciver
Journal:  Cell Motil Cytoskeleton       Date:  2005-03

6.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

7.  Proteome analysis of antiproliferative mechanism of 12-O-tetradecanoylphorbol 13-acetate on cultured nasopharyngeal carcinoma CNE2 cells.

Authors:  Peizhou Jiang; Ming Gan; Hua Huang; Xinming Shen; Shuang Wang; Kaitai Yao
Journal:  J Proteome Res       Date:  2005 Mar-Apr       Impact factor: 4.466

8.  Heat shock protein 27 enhances the tumorigenicity of immunogenic rat colon carcinoma cell clones.

Authors:  C Garrido; A Fromentin; B Bonnotte; N Favre; M Moutet; A P Arrigo; P Mehlen; E Solary
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

9.  HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma.

Authors:  L Lo Muzio; R Leonardi; M A Mariggiò; M D Mignogna; C Rubini; A Vinella; G Pannone; L Giannetti; R Serpico; N F Testa; G De Rosa; S Staibano
Journal:  Histol Histopathol       Date:  2004-01       Impact factor: 2.303

10.  Identification of altered protein expression and post-translational modifications in primary colorectal cancer by using agarose two-dimensional gel electrophoresis.

Authors:  Takeshi Tomonaga; Kazuyuki Matsushita; Seiko Yamaguchi; Masamichi Oh-Ishi; Yoshio Kodera; Tadakazu Maeda; Hideaki Shimada; Takenori Ochiai; Fumio Nomura
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

View more
  20 in total

1.  RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients.

Authors:  Jörg-Christian Heinrich; Anne Tuukkanen; Michael Schroeder; Torsten Fahrig; Rudolf Fahrig
Journal:  J Cancer Res Clin Oncol       Date:  2011-07-22       Impact factor: 4.553

2.  Quantitative patterns of Hsps in tubular adenoma compared with normal and tumor tissues reveal the value of Hsp10 and Hsp60 in early diagnosis of large bowel cancer.

Authors:  Francesca Rappa; Alessandro Pitruzzella; Antonella Marino Gammazza; Rosario Barone; Emanuele Mocciaro; Giovanni Tomasello; Francesco Carini; Felicia Farina; Giovanni Zummo; Everly Conway de Macario; Alberto Jl Macario; Francesco Cappello
Journal:  Cell Stress Chaperones       Date:  2016-08-04       Impact factor: 3.667

3.  Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer.

Authors:  Feng Wang; Peng Zhang; Chenzhang Shi; Yongzhi Yang; Huanlong Qin
Journal:  Med Oncol       Date:  2011-08-23       Impact factor: 3.064

4.  Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells.

Authors:  Yunlong Lei; Kai Huang; Cong Gao; Quek Choon Lau; Hua Pan; Ke Xie; Jingyi Li; Rui Liu; Tao Zhang; Na Xie; Huey Shan Nai; Hong Wu; Qiang Dong; Xia Zhao; Edouard C Nice; Canhua Huang; Yuquan Wei
Journal:  Mol Cell Proteomics       Date:  2011-05-27       Impact factor: 5.911

5.  Monitoring early responses to irradiation with dual-tracer micro-PET in dual-tumor bearing mice.

Authors:  Hui Wang; Bo Liu; Jia-He Tian; Bai-Xuan Xu; Zhi-Wei Guan; Bao-Lin Qu; Chang-Bin Liu; Rui-Min Wang; Ying-Mao Chen; Jin-Ming Zhang
Journal:  World J Gastroenterol       Date:  2010-11-21       Impact factor: 5.742

Review 6.  Innovations, challenges and future prospects of oncoproteomics.

Authors:  Kewal K Jain
Journal:  Mol Oncol       Date:  2008-05-28       Impact factor: 6.603

Review 7.  Revisiting the seed and soil in cancer metastasis.

Authors:  Martin Mendoza; Chand Khanna
Journal:  Int J Biochem Cell Biol       Date:  2009-02-03       Impact factor: 5.085

8.  Expression of HSP27, HSP72 and MRP proteins in in vitro co-culture of colon tumour cell spheroids with normal cells after incubation with rhTGF- beta1 and/or CPT-11.

Authors:  Roman Paduch; Joanna Jakubowicz-Gil; Martyna Kandefer-Szerszen
Journal:  J Biosci       Date:  2009-12       Impact factor: 1.826

9.  Fibersol-2 induces apoptosis of Apc-deficient colorectal Cancer (SW480) cells and decreases polyp formation in Apc MIN mice.

Authors:  Sara Cuesta Sancho; Susan Losee Olson; Eui Young So; Kazuhiro Shimomura; Toru Ouchi; Fabian Preuss
Journal:  Cancer Biol Ther       Date:  2016-05-04       Impact factor: 4.742

10.  Murine colon proteome and characterization of the protein pathways.

Authors:  Sameh Magdeldin; Yutaka Yoshida; Huiping Li; Yoshitaka Maeda; Munesuke Yokoyama; Shymaa Enany; Ying Zhang; Bo Xu; Hidehiko Fujinaka; Eishin Yaoita; Sei Sasaki; Tadashi Yamamoto
Journal:  BioData Min       Date:  2012-08-28       Impact factor: 2.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.